[The Nephrological Aspects of the Use of Rivaroxaban and Other Direct Peroral Anticoagulants in Non-Valvular Atrial

M M Batiushin1

  • 1Federal state budgetary educational institution of higher education "Rostov state medical University" of the Ministry of health of the Russian Federation.

Kardiologiia
|June 28, 2019
PubMed

Insights

Chronic kidney disease (CKD) significantly increases cardiovascular risks, including atrial fibrillation (AF). This review covers AF treatment in CKD patients, focusing on direct oral anticoagulants versus warfarin.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) is a major risk factor for cardiovascular events.
  • CKD is associated with increased risks of heart failure exacerbation, myocardial infarction, and cardiovascular mortality.
  • Atrial fibrillation (AF) is a notable adverse event in patients with CKD.

Purpose of the Study:

  • To discuss current therapeutic strategies for AF in patients across various stages of CKD.
  • To review the benefits of specific direct oral anticoagulants (DOACs) in this population.
  • To compare the efficacy and safety of DOACs with warfarin therapy.

Main Methods:

  • Literature review of current treatment approaches for AF in CKD.
  • Analysis of data on the benefits of DOACs in CKD patients.
  • Pharmacokinetic and pharmacodynamic evaluation of DOACs in relation to CKD.

Main Results:

  • DOACs offer benefits in managing AF in CKD patients.
  • Comparative data suggest specific DOACs may be advantageous over warfarin.
  • Understanding DOAC pharmacokinetics/pharmacodynamics is crucial for effective CKD therapy.

Conclusions:

  • Treatment of AF in CKD requires careful consideration of anticoagulation strategies.
  • DOACs represent a significant therapeutic option, with individualized selection based on CKD stage and drug properties.
  • Further research into optimal anticoagulation in CKD is warranted.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.2K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Amyloid Fibrils03:03

Amyloid Fibrils

6.4K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K